Holzgreve syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2167OMIM:236110Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Holzgreve syndrome, also known as Holzgreve-Wagner-Rehder syndrome, is an extremely rare lethal multiple congenital anomaly syndrome first described in 1988. The condition is characterized by a distinctive combination of renal agenesis or severe renal dysgenesis, internal genital malformations, and craniofacial anomalies including cleft palate and micrognathia. Additional features may include intestinal malformations, cardiac defects, and limb anomalies. The syndrome affects multiple organ systems including the urogenital, craniofacial, gastrointestinal, and cardiovascular systems. The condition typically presents prenatally or at birth and is generally considered lethal in the neonatal period. Oligohydramnios (reduced amniotic fluid) is frequently observed during pregnancy as a consequence of the severe renal abnormalities. The Potter sequence — comprising pulmonary hypoplasia, characteristic facial features, and limb positioning defects secondary to oligohydramnios — may also be present. Due to the extreme rarity and lethal nature of Holzgreve syndrome, there are no established treatments. Management is supportive and palliative. Only a very small number of cases have been reported in the medical literature, limiting the understanding of the full phenotypic spectrum and underlying genetic etiology. Genetic counseling is recommended for affected families, particularly given the suspected autosomal recessive inheritance pattern observed in some reported familial cases.

Also known as:

Clinical phenotype terms— hover any for plain English:

Single umbilical arteryHP:0001195Aplasia/Hypoplasia of the tongueHP:0010295Bifid tongueHP:0010297Abnormal mesentery morphologyHP:0100016Abnormally ossified vertebraeHP:0100569
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Holzgreve syndrome.

View clinical trials →

No actively recruiting trials found for Holzgreve syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Holzgreve syndrome community →

No specialists are currently listed for Holzgreve syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Holzgreve syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Holzgreve syndromeForum →

No community posts yet. Be the first to share your experience with Holzgreve syndrome.

Start the conversation →

Latest news about Holzgreve syndrome

No recent news articles for Holzgreve syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Holzgreve syndrome

What is Holzgreve syndrome?

Holzgreve syndrome, also known as Holzgreve-Wagner-Rehder syndrome, is an extremely rare lethal multiple congenital anomaly syndrome first described in 1988. The condition is characterized by a distinctive combination of renal agenesis or severe renal dysgenesis, internal genital malformations, and craniofacial anomalies including cleft palate and micrognathia. Additional features may include intestinal malformations, cardiac defects, and limb anomalies. The syndrome affects multiple organ systems including the urogenital, craniofacial, gastrointestinal, and cardiovascular systems. The condit

How is Holzgreve syndrome inherited?

Holzgreve syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Holzgreve syndrome typically begin?

Typical onset of Holzgreve syndrome is neonatal. Age of onset can vary across affected individuals.